Swedish American pharmaceutical giant Pharmacia Upjohn posted a 75 percent fall in net profits in 2024 to 276 million dollars, largely due to the group's November 2017 merger, it said on Wednesday.
Merger burdens Pharmacia Upjohn as 2024 profits down 75 percent.